on VALBIOTIS (EPA:ALVAL)
VALBIOTIS SA: Monthly update on voting rights and shares
On February 24, 2025, the French company VALBIOTIS SA published a regulatory update on the total number of voting rights and shares constituting its share capital. Listed on Euronext Growth Paris under ISIN code FR0013254851, Valbiotis declares a total of 15,794,596 shares as of December 31, 2024, with 16,463,811 theoretical voting rights and 16,436,379 exercisable voting rights. This press release is in compliance with Article 223-16 of the General Regulations of the Autorité des Marchés Financiers.
The company reminds shareholders of the information obligations in the event of crossing thresholds, in accordance with Articles L.233-7 et seq. of the French Commercial Code. Any failure to report may result in the suspension of voting rights associated with the shares. Valbiotis, which specializes in research into food supplements for metabolic disorders, is highlighting its local roots and strategic partnerships to promote its expansion.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VALBIOTIS news